GSE96917 adenosine 2 v 0 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE96917_adenosine_2_v_0_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE96917_adenosine_2_v_0_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE96917_adenosine_2_v_0_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE96917_adenosine_2_v_0_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

WD repeat domain 46

Gene

growth arrest specific 5

Gene

non-coding RNA activated by DNA damage

Gene

ZNFX1 antisense RNA 1

Gene

RNA polymerase II subunit J3

Gene

small nucleolar RNA host gene 15

Gene

small nucleolar RNA host gene 17

Gene

metastasis associated lung adenocarcinoma transcript 1

Gene

Morf4 family associated protein 1 like 2

Gene

HERPUD2 antisense RNA 1

  • Gene

    WD repeat domain 46


  • Gene

    growth arrest specific 5


  • Gene

    non-coding RNA activated by DNA damage


  • Gene

    ZNFX1 antisense RNA 1


  • Gene

    RNA polymerase II subunit J3


  • Gene

    small nucleolar RNA host gene 15


  • Gene

    small nucleolar RNA host gene 17


  • Gene

    metastasis associated lung adenocarcinoma transcript 1


  • Gene

    Morf4 family associated protein 1 like 2


  • Gene

    HERPUD2 antisense RNA 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.